| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.0016 | 1 |